HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Dah-Ren Hwang Selected Research

Schizophrenia (Dementia Praecox)

12/2012Synthesis and characterization of two PET radioligands for the metabotropic glutamate 1 (mGlu1) receptor.
6/2012Increased prefrontal cortical D₁ receptors in drug naive patients with schizophrenia: a PET study with [¹¹C]NNC112.
6/2011Measurement of the serotonin 1A receptor availability in patients with schizophrenia during treatment with the antipsychotic medication ziprasidone.
3/2010Increased synaptic dopamine function in associative regions of the striatum in schizophrenia.
12/2006Serotonin 1A receptor availability in patients with schizophrenia and schizo-affective disorder: a positron emission tomography imaging study with [11C]WAY 100635.
5/2006Modulation of amphetamine-induced dopamine release by group II metabotropic glutamate receptor agonist LY354740 in non-human primates studied with positron emission tomography.
6/2005Serotonin transporter availability in patients with schizophrenia: a positron emission tomography imaging study with [11C]DASB.
9/2003Dopamine depletion and in vivo binding of PET D1 receptor radioligands: implications for imaging studies in schizophrenia.
5/2002Prefrontal dopamine D1 receptors and working memory in schizophrenia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Dah-Ren Hwang Research Topics

Disease

9Schizophrenia (Dementia Praecox)
12/2012 - 05/2002
3Cocaine-Related Disorders (Cocaine Addiction)
06/2009 - 06/2004
2Alcoholism (Alcohol Abuse)
01/2009 - 11/2005
2Social Phobia
01/2009 - 12/2002
1Neuralgia (Stump Neuralgia)
12/2012
1Epilepsy (Aura)
12/2012
1Ischemia
12/2012
1Neoplasms (Cancer)
06/2011
1Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome)
06/2011
1Mood Disorders (Mood Disorder)
12/2006
1Seizures (Absence Seizure)
03/2005
1Mental Disorders (Mental Disorder)
03/2005
1Psychotic Disorders (Schizoaffective Disorder)
03/2005
1Anxiety Disorders (Anxiety Disorder)
12/2002
1Depressive Disorder (Melancholia)
12/2002

Drug/Important Bio-Agent (IBA)

7Dopamine (Intropin)FDA LinkGeneric
06/2012 - 09/2003
3Antipsychotic Agents (Antipsychotics)IBA
06/2012 - 03/2010
35-HT1A Serotonin ReceptorIBA
06/2011 - 12/2006
3Cocaine (Cocaine HCl)IBA
06/2009 - 06/2004
3Serotonin (5 Hydroxytryptamine)IBA
01/2009 - 12/2002
3Amphetamine (Amfetamine)FDA LinkGeneric
04/2007 - 11/2005
2Pharmaceutical PreparationsIBA
06/2012 - 05/2002
2N- (2- (4- (2- methoxyphenyl)- 1- piperazinyl)ethyl)- N- (2- pyridinyl)cyclohexanecarboxamideIBA
06/2011 - 12/2006
2Dopamine D1 Receptors (Dopamine D1 Receptor)IBA
06/2009 - 05/2002
2Serotonin Plasma Membrane Transport Proteins (Serotonin Transporter)IBA
01/2009 - 06/2005
2Dopamine D2 Receptors (Dopamine D2 Receptor)IBA
01/2009 - 06/2004
2NNC 112IBA
09/2003 - 05/2002
1Glutamic Acid (Glutamate)FDA Link
12/2012
1Proteins (Proteins, Gene)FDA Link
12/2012
1ziprasidone (Geodon)FDA Link
06/2011
11,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA
06/2011
1conatumumabIBA
06/2011
1CopperIBA
06/2011
1Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA
01/2009
1KetamineFDA LinkGeneric
05/2006
1N-Methylaspartate (NMDA)IBA
05/2006
13- amino- 4- (2- dimethylaminomethylphenylsulfanyl)benzonitrileIBA
06/2005
1kappa Opioid Receptors (kappa Opioid Receptor)IBA
03/2005
1ORALIT (ORS)IBA
03/2005
1SCH 23390IBA
09/2003
1Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA
12/2002
1Paroxetine (Paxil)FDA LinkGeneric
12/2002
1McN 5652IBA
12/2002